eClinical Solutions Appoints Nathan Johnson, Brian Testa and Jessica Allen to C-Suite Roles

eClinical Solutions appointed Nathan Johnson as Chief Product Officer, Brian Testa as Chief People Officer and Jessica Allen as Chief Financial Officer, the company said on October 22, 2026. The Mansfield-based clinical software provider announced the three appointments in a Business Wire release.

eClinical Solutions Fills Three Executive Roles

Johnson has been with eClinical Solutions for more than half a decade and previously served as VP of Product Management, VP of Digital Innovation and Director of Data Engineering. In his new role he will lead product strategy and roadmap, with a focus on advancing the elluminate Clinical Data Intelligence Platform. He holds a Master of Science in Biostatistics from Case Western Reserve University.

Testa brings more than 20 years of executive leadership experience across technology, healthcare, life sciences and high-growth businesses. He was most recently Chief People Officer at iCAD, a publicly traded life sciences organization, where he led the company's people strategy through a period of transformation and strategic change. At eClinical Solutions he will lead the People and Culture strategy. He holds a Bachelor of Applied Science from Nichols College.

Allen brings nearly two decades of financial leadership experience across healthcare technology, public companies, private equity-backed organizations and global enterprises. She joins from Aetion, acquired by Datavant, where she was Senior Vice President of Finance and Accounting and led Accounting, FP&A, treasury, tax and investor relations. Earlier roles included Amwell, Verizon, Fleetmatics and Rolls-Royce. She holds a Bachelor of Science in Financial Management from Mount Vernon Nazarene University.

"We're energized by the deep expertise each of these strategic leaders bring to our executive team," said Raj Indupuri, CEO and co-founder of eClinical Solutions. "Their roles will be critical as we scale, deepen our AI offerings, and continue to accelerate cycle times."

eClinical Solutions' Earlier Leadership and Platform Moves

According to akta.pro company records, eClinical Solutions appointed Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer in March 2026, formalizing executive leadership for operational scaling and an AI-first strategy following the GI Partners investment. The same records list two private equity funding rounds, led by Summit Partners in January 2020 and GI Partners in September 2024.

Events Leading to the Appointments

In October 2026, eClinical Solutions said it would host its eighth annual ENGAGE 2026 conference from October 12 to 14 at W Philadelphia, with more than 250 attendees from over 75 life science organizations, according to FinancialContent Business Page. In July 2026, CEO Raj Indupuri discussed the operational demands of the FDA's push toward continuous data review in clinical trials in a Q&A with Applied Clinical Trials. In June 2026, the company announced enhanced risk-based quality management features within elluminate, including new workflows for risk assessments and site and country performance insights, FinancialContent Business Page said.

The company said it has added over 15 net new life sciences customers and partners to date in 2026 and now supports 19 of the top 50 pharmaceutical companies and CROs with its elluminate platform. More information on the leadership team is available on the company's website.